Ignite Creation Date:
2025-12-24 @ 7:33 PM
Ignite Modification Date:
2025-12-28 @ 5:39 AM
Study NCT ID:
NCT04577703
Status:
COMPLETED
Last Update Posted:
2020-10-08
First Post:
2020-09-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
First-In-Human Phase I Trial of Ningetinib ( CT053PTSA ) in the Patients With Advanced Solid Tumors
Sponsor:
Sunshine Lake Pharma Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-02-08
Start Date Type:
ACTUAL
Primary Completion Date:
2015-12-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-12-10
Completion Date Type:
ACTUAL
First Submit Date:
2020-09-16
First Submit QC Date:
None
Study First Post Date:
2020-10-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-09-30
Last Update Post Date:
2020-10-08
Last Update Post Date Type:
ACTUAL